GeneOne Life Science, Inc. (KRX:011000)

GeneOne Life Science Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Feb 4, 2026	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	167,589	168,840	222,271	553,651	1,250,928	961,062
Market Cap Growth	-22.53%	-24.04%	-59.85%	-55.74%	30.16%	1733.31%
Enterprise Value	195,267	188,532	219,584	509,945	1,241,186	881,347
Last Close Price	1967.00	2115.00	2840.00	7140.00	16200.00	13850.76
PS Ratio	5.42	4.73	5.53	11.36	32.32	23.16
PB Ratio	3.03	1.97	1.99	3.05	6.06	9.76
P/TBV Ratio	3.04	1.98	2.00	3.06	6.08	9.82
EV/Sales Ratio	6.32	5.28	5.46	10.47	32.07	21.24
Debt / Equity Ratio	0.55	0.32	0.15	0.11	0.09	0.18
Asset Turnover	0.23	0.24	0.22	0.21	0.20	0.44
Inventory Turnover	2.76	2.97	3.23	3.10	3.17	3.55
Quick Ratio	0.14	0.24	0.77	1.66	3.36	2.68
Current Ratio	0.50	0.67	1.51	2.16	3.87	2.96
Return on Equity (ROE)	-71.52%	-49.25%	-53.09%	-19.67%	-10.42%	-30.43%
Return on Assets (ROA)	-19.32%	-17.79%	-16.17%	-10.61%	-8.88%	-12.34%
Return on Capital Employed (ROCE)	-52.60%	-39.50%	-37.70%	-21.30%	-12.70%	-18.60%
Earnings Yield	-30.65%	-28.75%	-34.99%	-6.89%	-1.27%	-1.94%
FCF Yield	-10.21%	-11.46%	-12.30%	-12.54%	-6.98%	-3.34%
Buyback Yield / Dilution	-3.63%	-2.20%	-0.34%	-4.37%	-22.98%	-88.03%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.